Int. J. Radiat. Oncol. Biol. Phys. 2020 Jan 29
MRI-guided ultrafocal salvage high-dose-rate brachytherapy for localized radiorecurrent prostate cancer: updated results of 50 patients.
van Son MJ, Peters M, Moerland MA, Lagendijk JJW, Eppinga WSC, Shah TT, Ahmed HU, van der Voort van Zyp JRN
Most patients with local prostate cancer recurrence after radiation therapy undergo palliative androgen deprivation therapy (ADT), since whole-gland s ...
Read More
Source: PubMed
Urologiia
[Minimally invasive techniques of localized prostate cancer].
Chinenov DV, Shpot EV, Chernov YN, Amosov AV, Enikeev DV, Krupinov GE, Petrovskyi NV, Olifirova KP
Currently, prostate cancer (PCa) is one of the most important problem of modern medicine, including economical issue. The detection of PCa compared to ...
Read More
Source: PubMed
Eur. Urol. 2020 Jan 27
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.
Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow RG, Chi KN, Clarke N, Davis ID, de Bono J, Drake CG, Duran I, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng FY, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Heinrich D, Higano CTS, Hofman MS, Hussain M, James N, Kanesvaran R, Kantoff P, Khauli RB, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans AK, Morris MJ, Mottet N, Mrabti H, Murphy DG, Murthy V, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Parker C, Poon DMC, Pritchard CC, Reiter RE, Roach M, Rubin M, Ryan CJ, Saad F, Sade JP, Sartor O, Scher HI, Shore N, Small E, Smith M, Soule H, Sternberg CN, Steuber T, Suzuki H, Sweeney C, Sydes MR, Taplin ME, Tombal B, Türkeri L, van Oort I, Zapatero A, Omlin A
Innovations in treatments, imaging, and molecular characterisation in advanced prostate cancer have improved outcomes, but there are still many aspect ...
Read More
Source: PubMed
Pathol. Res. Pract. 2020 Jan 10
Clinical and pathological characteristics of bladder cancer in post brachytherapy patients.
Au S, Keyes M, Black P, Villamil CF, Tavassoli P
The long-term risk of secondary malignancy is a potential late effect of brachytherapy. However, the time interval, anatomic site and histopathology a ...
Read More
Source: PubMed
Radiother Oncol
Variation in radiotherapy patterns of care in the radical treatment of South Australian men with non-metastatic prostate cancer between 2005-2015.
Morias S, Buckley E, Beckmann K, O'Callaghan M, Borg M, Short M
To investigate associations between socio-demographic characteristics and radiotherapy patterns of care in non-metastatic prostate cancer [nmPCa] in S ...
Read More
Source: PubMed